Salesforce

Measure Paper - CMS 2022 Measure 145v10 for NextGen Office

Printable View
« Go Back

Information

 
Application Version
Program/Measure YearMIPS 2022
Build Version
Document Summary
DomainEffective Clinical Care
Measure NameCoronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)
DescriptionPercentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12-month period who also have a prior MI or a current or prior LVEF < 40% who were prescribed beta-blocker therapy.
Attachment 1
Attachment 2
Attachment 3
Attachment 4
Attachment 5
KeywordseCQM MIPS CMS145 "coronary artery disease" CAD "myocardial infarction" MI beta-blocker "beta blocker" "left ventricular systolic dysfunction" LVEF
TitleMeasure Paper - CMS 2022 Measure 145v10 for NextGen Office
URL NameCMS145
Powered by